Reviewing critical TRPM2 variants through a structure-function lens

Ádám V Tóth1, Ádám Bartók1

  • 1Department of Biochemistry, Semmelweis University, 37-47 Tűzoltó street, Budapest 1094, Hungary; HCEMM-SE Molecular Channelopathies Research Group, 37-47 Tűzoltó street, Budapest 1094, Hungary; HUN-REN-SE Ion Channel Research Group, 37-47 Tűzoltó street, Budapest 1094, Hungary.

PubMed

Insights

Transient Receptor Potential Melastatin 2 (TRPM2) channels link cell redox state to calcium signaling. This review examines TRPM2 genetic variants and their potential roles in neurodegenerative diseases and mental disorders.

Area of Science:

  • Molecular Biology
  • Cell Physiology
  • Genetics

Background:

  • The TRPM2 channel is crucial for linking cellular redox state to calcium signaling.
  • TRPM2 is implicated in both normal physiological processes and diseases like neuronal cell death and ischemia-reperfusion injury.
  • Genetic variations in TRPM2 are associated with mental and neurodegenerative disorders in humans.

Purpose of the Study:

  • To review documented single nucleotide variants (SNVs) in the TRPM2 gene.
  • To discuss evidence linking these SNVs to disease associations.
  • To interpret the molecular impact of amino acid substitutions caused by these SNVs using structural data.

Main Methods:

  • Literature review of genetic studies and exome sequencing data.
  • Analysis of four well-documented TRPM2 SNVs (rs1556314, rs139554968, rs35288229, rs145947009).
  • Interpretation of amino acid substitutions (D543E, R707C, R755C, P1018L) based on human TRPM2 structures.

Main Results:

  • Identified one common and three rare TRPM2 SNVs associated with potential disease links.
  • Examined evidence for and against the association of these variants with specific diseases.
  • Provided molecular interpretations of the functional consequences of these amino acid changes.

Conclusions:

  • Studying TRPM2 variants, especially rare ones, can offer insights into disease mechanisms.
  • TRPM2 mutations may represent novel therapeutic targets for neurological and psychiatric conditions.
  • Further research is needed to validate these hypotheses and explore therapeutic potential.